I have been following this on volume after the offering and have liked it so far. Decent channel + they have approved drug which is/was scheduled to hit the market in 2Q but might be pushed back much further due to the coronavirus.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
